Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab + MTX in RA (DE019)
NCT00195702Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Feb 2000
- Primary completion
- Sep 2002
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Abbott Laboratories. Started Feb 2000; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00195702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195702.